Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
2005-02-08
2005-02-08
Shukla, Ram R. (Department: 1632)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C435S355000, C435S325000
Reexamination Certificate
active
06852533
ABSTRACT:
The invention is directed to a purified population of mammalian endothelial, muscle, or neural stem cells. The invention further provides methods for isolating such populations of cells; methods for using such populations of cells for treating mammals; methods for making vectors for gene therapy; and methods for carrying out gene therapy with such vectors.
REFERENCES:
patent: 5035994 (1991-07-01), Civin
patent: 5061620 (1991-10-01), Tsukamoto et al.
patent: 5130144 (1992-07-01), Civin
patent: 5283354 (1994-02-01), Lemischka
patent: 5328695 (1994-07-01), Lucas et al.
patent: 5468612 (1995-11-01), Cohen et al.
patent: 5599703 (1997-02-01), Davis et al.
patent: 5672499 (1997-09-01), Anderson et al.
patent: 5674722 (1997-10-01), Mulligan et al.
patent: 5733541 (1998-03-01), Taichman et al.
patent: 5747651 (1998-05-01), Lemischka
patent: 5843633 (1998-12-01), Yin et al.
patent: 6204011 (2001-03-01), Kendall et al.
patent: WO 9411499 (1994-05-01), None
patent: WO 9640769 (1996-06-01), None
patent: WO 9800523 (1997-07-01), None
Peichev et al. Blood 95:952-958, 2000.*
TP Yamaguchi et al., Development, “flk-1, and flt-related receptor tyrosine kinase is an early marker for endothlial cell precursors,” 1993, 118, 489-498.*
UM Gehling et al., Blood, “In vitro differentiation of endothelial cells from AC133-positive progenitor cells,”May 2000, vol. 95, No. 10, pp. 3106-3112.*
S. Rafii et al., Blood, “Rapid Communication,” Jul. 1994, vol. 84, No. 1, pp. 10-19.*
Almedia-Porada, J. Lab. Clin. Med. 128, 399-407 (1996).*
Vittet et al., Blood 88 3424-3431 (1996).*
Stemple, Cell 71, 973-985 (1992).*
Masek et al., Experimental Hematology 22, 1203-1209 (1994).*
Rohwedel, Development Biology 164, 87-101 (1994).*
Miraglia, et al., A Novel Five-Transmembrane Hematopoietic Stem Cell Antigen: Isolation, Characterization, and Molecular Cloning, Blood 90, 5013-5021 (1997).
Asahara, et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis, Science 275, 946-967 (1997).
Eichmann et al., Ligand-Dependent Development of the Endothelial and Hemopoietic Lineages from Embroyonic Mesodermal Cells Expressing Vascular Endothelial Growth Factor Receptor 2, Proc. Natl. Acad. Sci. USA 94, 5141-5146 (1997).
New York Times, Brain Stem Cell Is Discovered Twice, Jun. 16, 1999.
Shalaby, et al., A Requirement for Flkl in Primitive and Definitive Hematopoiesis and Vasculogenesis, Cell 39, 981-990 (1997).
Pepper, Michael, S., Manipulating Angiogenesis Arteriosclerosis, Thrombosis, and Vascular Biology 17, 605-619(1997).
Yin, et al., AC133, A Novel Marker for human Hematopoietic Stem and Progenitor Cells, Blood 90, 5002-5012(1997).
Moore Malcolm A. S.
Rafii Shahin
Witte Larry
Cornell Research Foundation Inc.
ImClone System Incorporated
Kenyon & Kenyon
Shukla Ram R.
Sloan-Kettering Institute for Cancer Research
LandOfFree
Purified populations of stem cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purified populations of stem cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified populations of stem cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3513967